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ABSTRACT (max 140 words) 
Ribosomes synthesizing proteins containing consecutive proline residues become stalled 
and require rescue via the action of uniquely modified translation elongation factors, EF-
P in bacteria or archaeal/eukaryotic a/eIF5A. To date no structures exist of EF-P or 
eIF5A in complex with translating ribosomes stalled at a polyproline stretch and thus 
structural insight into how EF-P/eIF5A rescue these arrested ribosomes has been lacking. 
Here we present cryo-EM structures of ribosomes stalled on proline stretches, without 
and with modified EF-P. The structures suggest that the favored conformation of the 
polyproline-containing nascent chain is incompatible with the peptide exit tunnel of the 
ribosome and leads to destabilization of the peptidyl-tRNA. Binding of EF-P stabilizes 
the P-site tRNA, particularly via interactions between its modification and the CCA-end, 
thereby enforcing an alternative conformation of the polyproline-containing nascent 
chain, which promotes a favorable geometry for peptide bond formation.  
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Ribosomes catalyze the synthesis of proteins in cells by providing a platform for the 
binding of tRNAs. There are three tRNA binding sites on the ribosome, the A-, P- and E-
sites. During translation elongation, aminoacyl-tRNAs (aa-tRNAs) binding at the A-site 
undergo peptide bond formation with the peptidyl-tRNA located at the P-site. The rate of 
peptide bond formation is influenced by the chemical nature of the amino acid substrates 
in both the A- and P-sites. Among other amino acids, proline is a particularly poor 
substrate both as donor and acceptor during peptide bond formation1-6. In fact, ribosomes 
become stalled when ribosomes synthesize proteins containing consecutive proline 
residues5,7,8. To alleviate the ribosome stalling and allow translation to continue, a 
specialized translation factor is required, elongation factor P (EF-P) in bacteria or 
initiation factor 5A (IF5A) in archaea and eukaryotes5,7,9. IF5A has been shown to be 
essential in eukaryotes10 and deletion of efp in some bacteria leads to growth defects and 
avirulence11. 
Both EF-P and IF5A bear post-translational modifications that are essential for 
their rescue activity5,7,9,12. In Escherichia coli, lysine 34 (K34) of EF-P is post-
translationally modified by the combined action of EpmA (YjeA), EpmB (YjeK) and 
EpmC (YfcM). EpmB converts (S)-α-lysine to (R)-β-lysine13 and EpmA ligates the (R)-
β-lysine to the ε-amino group of K3414,15. EpmC recognizes the modified form of EF-P 
and hydroxylates the C5(δ) of K3416, however, the hydroxylation is not required for the 
rescue activity of EF-P5,7. Surprisingly, the resulting ε(R)-β-lysylhydroxylysine 
modification of E. coli EF-P and the enzymes associated with this modification are not 
conserved across all bacteria17,18. Instead, unrelated enzymes and/or modifications have 
been identified in other bacteria. In Pseudomonas aeruginosa and Shewanella oneidensis 
EarP catalyzes the addition of rhamnose to arginine 32 (R32) of EF-P18,19, whereas 
Bacillus subtilis is reported to bear an 5-aminopentanol moiety attached to K3220. In 
eukaryotes, a conserved lysine residue is post-translationally modified to hypusine by the 
action of deoxyhypusine synthase (DHS) and deoxyhypusine hydroxylase (DOHH)10,11.  
The structure of bacterial EF-P revealed a three-domain architecture, with the 
modified residue located at the tip of domain 121. aIF5A and eIF5A are homologous to 
bacterial EF-P domains 1 and 2, but lack the bacterial-specific domain 310,11. The X-ray 
structure of unmodified Thermus thermophilus EF-P in complex with T. thermophilus 
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70S ribosome bearing a deacylated tRNAfMet at the P-site revealed that EF-P binds within 
the E-site of the ribosome with the unmodified arginine 32 (R32) of EF-P interacting with 
the CCA-end of the P-site tRNA22. Similarly, structures of modified eIF5A on the yeast 
ribosome also visualized the hypusine modification extending into the peptidyltransferase 
center (PTC) of the ribosome23,24 where it interacts with the CCA-end of the P-site 
tRNA24. However, to date no structures exist of EF-P or eIF5A in complex with 
polyproline-stalled ribosomes, therefore, it remains unclear how the proline residues stall 
translation and how EF-P/IF5A alleviates these stalled ribosomes. 
 
RESULTS 
Structure of a polyproline-stalled ribosome complex 
To investigate how polyproline stretches cause translational arrest, we employed a 
previously used reporter mRNA coding for NlpD-PPP protein bearing three consecutive 
proline (71PPP73) residues25 (Fig. 1a), which was translated in an E. coli lysate based S30 
translation system derived from an E. coli efp deletion strain (see Methods). As 
expected25, ribosomes with peptidyl-tRNA stalled at the PPP stretch could be alleviated 
by the exogenous addition of purified modified EF-P protein (Fig. 1a). Previous 
biochemical studies5,7,8, as well as toeprinting assays using the same NlpD-PPP 
template25, indicate that ribosomes stall in the absence of EF-P because of slow peptide 
bond formation between the peptidyl-Pro-Pro-tRNA in the P-site and the incoming Pro-
tRNA in the A-site (Fig. 1b). These PPP-stalled ribosomes were purified using the 
6 x Histidine-tag located at the N-terminus of the nascent peptide (Fig. 1b) and subjected 
to cryo-EM analysis (see Methods). In silico sorting of the cryo-EM images yielded two 
subpopulations of non-rotated ribosomes bearing a P-site tRNA, but differing by the 
absence or presence of A-site tRNA (17% and 44%, respectively; Supplementary Fig. 
1a). The cryo-EM structures were refined to yield average resolutions of 3.6 Å and 3.9 Å, 
respectively (Fig. 1c,d, Table 1 and Supplementary Fig. 1b-e). In addition, a large 
population (30%) of vacant ribosomes was observed as well as a small population (9%) 
of 70S ribosomes in a rotated state with hybrid A/P-site and P/E-site tRNAs 
(Supplementary Fig. 1a), the latter presumably representing a post-peptide bond 
formation state. 
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The density quality and resolution for the A-site and P-site tRNAs was generally 
poorer and less uniform than observed in previous ribosomal complexes26-28. In particular, 
the density was well resolved for the anticodon stem loop (ASL) of the tRNA on the 30S 
subunit and progressively deteriorated towards the elbow and acceptor arm of the tRNAs 
on the 50S subunit (Fig. 1e,f and Supplementary Fig. 2a-g). In fact, density for the 
CCA-end of the P- and A-site tRNAs at the PTC was only present at low thresholds (Fig. 
1g, h). Local resolution calculations also confirmed the flexible nature of the CCA-end, 
particularly with respect to the terminal A76 nucleotide (Supplementary Fig. 2h-j). In 
the structure containing only P-site tRNA, no significant density was observed for the 
nascent polypeptide chain (Fig. 1g), whereas in the structure with both A- and P-site 
tRNAs, the density attributable to the nascent chain was fragmented and disconnected 
from the tRNAs (Fig. 1h). The density for the CCA-end of the A-site tRNA was worse 
than the P-site tRNA (Fig. 1d and Supplementary Fig. 2d-g), suggesting that the Pro-
tRNA had severe problems to accommodate at the A-site of the PTC. Consistent with this 
notion, the N-terminus of ribosomal protein L27, which becomes stabilized upon A-site 
tRNA accommodation29,30, remained disordered (Supplementary Fig. 2k).  
 The destabilization of the peptidyl-tRNA observed within the structures of the 
PPP-stalled ribosomes is compatible with the observed peptidyl-tRNA drop-off that was 
reported to occur when ribosomes stall during translation of short polyproline-containing 
peptides5,6. Indeed, peptidyl-tRNA destabilization, coupled with peptide release and/or 
ribosome rescue within the translation extracts, may explain the unusually high 
proportion (30%) of vacant 70S ribosomes that were present in the PPP-stalled ribosome 
sample following purification (Supplementary Fig. 1a). Collectively, our findings 
suggest that the presence of the polyproline stretch within the nascent polypeptide chain 
leads to destabilization of the peptidyl-tRNA and prevents accommodation of the aa-
tRNA at the A-site, thereby causing translational stalling.  
 
EF-P in complex with PPP-stalled ribosomes 
To investigate structurally how EF-P relieves the translation arrest caused by polyproline 
stretches, PPP-stalled ribosomes were incubated with fully-modified E. coli EF-P (Fig. 
2a) and the resulting complexes were analyzed by cryo-EM. In silico sorting of the cryo-
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EM data yielded two major subpopulations of ribosomes bearing P-tRNA, distinguished 
by the presence (30%) or absence of EF-P (33%) (Supplementary Fig. 1f). The EF-P-
containing subpopulation was extremely heterogeneous and only a stable subpopulation 
containing A- and P-site tRNAs with EF-P bound in the E-site (Fig. 2b) could be refined 
further, yielding an average resolution of 3.7 Å (Table 1 and Supplementary Fig. 1g,h). 
Despite multiple attempts, we were unable to obtain a clean subpopulation containing P-
site tRNA and EF-P, but lacking A-site tRNA. For completeness, we also refined the 
major P-site tRNA subpopulation lacking EF-P (Fig. 2c) to an average resolution of 
3.2 Å (Table 1 and Supplementary Fig. 1i,j). As before (Fig. 1g), little density was 
observed for the nascent polypeptide chain attached to the P-site tRNA in the EF-P 
lacking structure (Fig. 2d), despite the improved quality of the density for the CCA-end 
of the P-site tRNA. By contrast, additional nascent chain density was observed when EF-
P was present (Fig. 2e), however, this density fused directly to the A-site tRNA, rather 
than the P-site tRNA (Fig. 2f). Therefore, we concluded that the EF-P-containing 
subpopulation represents a post-peptide bond formation state with deacylated tRNA in 
the P-site and peptidyl-tRNA in the A-site. We also observe that the N-terminus of L27 
was ordered (Fig. 2g), which as mentioned is diagnostic for accommodation of the aa-
tRNA at the A-site29,30. 
 
EF-P in complex with PP-stalled ribosomes without the A-tRNA 
In order to capture EF-P bound to polyproline-stalled ribosomes in a pre-peptide bond 
formation state, we employed a modified version of the NlpD-PPP mRNA that was 
truncated directly after the codon for the second proline of the PPP motif (Fig. 3a). 
Ribosomes translating the truncated NlpD-PP mRNA become stalled after the PP-motif 
because the absence of an A-site codon precludes binding of the next aa-tRNA, thus the 
ribosomes cannot catalyze peptide bond formation even when EF-P is present (Fig. 3a). 
The purified truncated NlpD-PP-stalled ribosomes were then incubated with active 
modified E. coli EF-P (Fig. 3a) and the resulting complexes were analyzed by cryo-EM. 
In silico sorting of the cryo-EM data yielded two major subpopulations of ribosomes 
bearing either P- and E-site tRNAs (22%) or P-site tRNA with EF-P bound in the E-site 
(74%) (Supplementary Fig. 1k). The EF-P containing subpopulation could be further 
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segregated into ribosome populations that differed with respect to the L1 stalk adopting 
an “in” (30%) or “out” (44%) conformation. The “in” position of the L1 stalk 
significantly improved the quality of the EF-P density and therefore this population was 
further refined, yielding a final cryo-EM structure (Fig. 3b) with an average resolution of 
3.1 Å (Table 1 and Supplementary Fig. 1l,m). Similarly, we could also refine the major 
P- and E-site tRNA containing ribosome subpopulation that lacked EF-P (Fig. 3c) to a 
final average resolution of 3.2 Å (Supplementary Fig. 1n,o). Local resolution 
calculations indicate less flexibility of the P-site tRNA in the presence of EF-P (Fig. 3d) 
when compared to ribosomes bound with E-site tRNA (Fig. 3e) or having a vacant E-site 
(Fig. 3f), thus supporting the hypothesis that EF-P stabilizes the P-site peptidyl-tRNA on 
the ribosome. 
 
EF-P residues critical for P-site tRNA interaction  
The well-resolved density for E. coli EF-P bound to the ribosome population with the L1-
“in” conformation enabled a complete molecular model to be generated (Fig. 4a and 
Supplementary Fig. 3a). The overall conformation of E. coli EF-P on a polyproline-
stalled ribosome is very similar to that observed by X-ray crystallography for 
T. thermophilus EF-P bound to a T. thermophilus 70S ribosome with a deacylated-
tRNAfMet in the P-site22, whereas it deviates more significantly from the binding position 
observed for the yeast homologue eIF5A bound to the 80S ribosome23,24 
(Supplementary Fig. 3b-c). We observe that the backbone of Asp69 of E. coli EF-P is 
within hydrogen bonding distance of U17a within the D-loop of the peptidyl-tRNAPro in 
the P-site (Supplementary Fig. 3d). This interaction is also observed in the 
T. thermophilus EF-P-ribosome structure22 (Supplementary Fig. 3e), but is not possible 
for tRNAs containing shorter D-loops (Supplementary Fig. 3f), thus providing a 
specificity determinant for EF-P to recognize tRNAfMet and tRNAPro [Ref. 31] 
(Supplementary Fig. 3d,e). By contrast, such a specific interaction between yeast eIF5A 
and the P-site tRNA was not observed23,24, consistent with the diverse range of non-
proline containing stalling motifs that are recognized and rescued by eIF5A32,33. 
Unlike eIF5A, bacterial EF-P has an additional domain 3 that contacts the small 
ribosomal subunit and the ASL of the P-site tRNA (Fig. 4b). In particular, two conserved 
 8 
residues Tyr183 and Arg186 are within hydrogen bonding distance of A42 of the P-site 
tRNA and G1338 within helix h29 of the 16S rRNA22 (Fig. 4b). To investigate the 
importance of these interactions, we generated modified EF-P variants bearing Y183A or 
R186A substitutions, and monitored their ability to promote translation of a polyproline-
containing firefly luciferase (Fluc) reporter protein7 (Fig. 4c). In the absence of EF-P, 
ribosomes stall at the polyproline motif and little or no luminescence is observed because 
translation of full-length Fluc is prevented. As expected, addition of modified active EF-P 
rescues the polyproline-stalled ribosomes, leading to production of full-length Fluc and a 
corresponding increase in luminescence (Fig. 4c). By contrast, the EF-P-Y183A and EF-
P-R186A variants were both completely inactive, as was the previously reported inactive 
EF-P-K34A variant5,7. These findings demonstrate that the Tyr183 and Arg186 residues 
are critical for the rescue activity of EF-P and explain their high conservation among 
bacterial EF-P proteins. 
 
Interaction of EF-P with the mRNA codon in the E site. 
In the X-ray structure of T. thermophilus EF-P-ribosome structure, loop I of domain 3 of 
EF-P is disordered22 (Fig. 4d). By contrast, loop I is well-resolved in the cryo-EM 
structure of E. coli EF-P in complex with the PP-stalled ribosome (Fig. 4a and 
Supplementary Fig. 4a, b) where it interacts with the ribosomal protein S7 and E-site 
codon of the mRNA (Fig. 4d, e). Binding of EF-P to the ribosome leads to a shift in 
conformation of the β-hairpin of S7 by 7.4 Å (Fig. 4d), which is stabilized via potential 
hydrogen bond interactions between the sidechain of Arg78 of S7 with the backbone of 
Gly144 and the sidechain of T146 of EF-P (Fig. 4d). Additional interactions are formed 
between Thr83 and Ser82 of S7 with the backbone of Leu142 and the Asp139 sidechain 
of EF-P (Fig. 4e and Supplementary Fig. 4c,d). Loop I of domain 3 of EF-P contains a 
highly conserved Gly144-Asp145-Thr146 (GDT) motif, which establishes contact with 
the nucleobase of the first and second positions of the E-site codon of the mRNA (Fig. 
4d,e and Supplementary Fig. 4e,f). To assess the importance of the GDT motif for EF-P 
activity, we generated modified EF-P bearing a triple substitution of GDT to AAA (EF-P-
144AAA146). Since most of the interactions involve the backbone of the GDT motif, we 
also generated EF-P variants where 1, 2 or 4 residues within loop I were deleted (EF-P-
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loopIΔ1, -loopIΔ2 and -loopIΔ4, respectively). The activity of the EF-P variants was 
assessed by monitoring the formation of fMPPPF peptide on the ribosome, as described 
previously5,6. As seen in Figure 4f, no fMPPPF peptide was synthesized when EF-P was 
absent, or when the inactive EF-P-K34A variant was used, whereas the presence of 
wildtype EF-P led to efficient fMPPPF peptide formation. While the EF-P-loopIΔ1 
retained wildtype-like activity, the EF-P-144AAA146 and EF-P-loopIΔ2 variants displayed 
reduced activity, and the EF-P-loopIΔ4 variant was completely inactive (Fig. 4f). 
Furthermore, an EF-P variant with the complete domain 3 deleted (EF-P-ΔDomain 3) 
was also inactive (Fig. 4f).  
These results suggest that the conserved loop I of domain 3 of EF-P is critical for 
the rescue activity of EF-P and raises the possibility that EF-P recognizes the nature of 
the E-site codon, analogous to stop codon recognition by the SPF and PXT containing 
loops of termination RF2 and RF1, respectively34. Modeling on the basis of our structure 
suggests that purines in the first and second position, such as AAA or GGG codons, in 
the E-site leads to clashes with EF-P, whereas UUU could be accommodated but in a less 
stable manner (Supplementary Fig. 5a-d). In the X-ray structure of T. thermophilus EF-
P-ribosome structure, the E-site codon was AAA22 (Supplementary Fig. 5e,f), possibly 
explaining why loop I of domain 3 of EF-P was disordered. Moreover, the -3 nucleotide 
was also not visualized, supporting the suggestion that EF-P is critical for positioning and 
stabilization of the E-site codon (Supplementary Fig. 5e,f). Further biochemical 
experiments will be necessary to assess whether loop I of EF-P can really distinguish 
CCN proline codons in the E-site from other sense codons, and to what extent. The 
absence of domain 3 in eIF5A does however preclude recognition of the nature of the E-
site codon, which may contribute to the relaxed specificity of eIF5A, allowing eIF5A to 
also act on a diverse range of non-proline containing stalling motifs32,33. 
 
Stabilization of the CCA-end of the P-tRNA by the EF-P modification 
Clear electron density is observed at the tip of domain 1 of EF-P that corresponds to the 
ε(R)-β-lysylhydroxylysine located at position K34 of EF-P (Fig. 5a,b). The post-
translation modification extends into a crevice located adjacent to the CCA-end of the P-
site tRNA (Fig. 5a,b), similar but distinct from that observed previously for the 
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unmodified R32 residues of T. thermophilus EF-P22, and the hypusine modification 
located at position K51 of yeast eIF5A23,24 (Supplementary Fig. 3g-i). The structure 
reveals how the EF-P modification can stabilize the P-site tRNA (Fig. 5c) via forming 
interactions with the backbone of the CCA-end (Fig. 5b). Specifically, hydrogen bonds 
are possible between the ε-amino group of the (R)-lysyl moiety of EF-P and the 2’ OH of 
the ribose of C75 and the bridging oxygen of A76 (Fig. 5b). Furthermore, the hydroxyl 
group that is post-translationally added to K34 of EF-P by EpmC16 comes within 
hydrogen binding distance of the 2’ OH of C74, but this interaction is unlikely to be 
critical since EF-P lacking the hydroxylation retains rescue activity5,7,12. In addition, the 
EF-P modification can form hydrogen bonds with the conserved nucleotide A2439 of the 
23S rRNA (Fig. 5b), analogous to those formed between eIF5A and A280823,24, the 
equivalent residue in the yeast 28S rRNA (Supplementary Fig. 3i). By contrast, the 
overall position and interactions of the modified K34 residue of E. coli EF-P differs 
dramatically from that of the unmodified R32 residues of T. thermophilus EF-P22, which 
is significantly shorter and interacts only with the nucleobase of C75 of the P-site tRNA 
(Supplementary Fig. 3h).  
 
The conformation of the nascent chain in the presence of EF-P 
The presence of additional density for the nascent polypeptide chain attached to the P-
tRNA (Fig. 5c,d) suggests that by stabilizing the P-site tRNA, EF-P also indirectly 
stabilizes the nascent chain. Nevertheless, local resolution calculations indicate that the 
nascent chain is still relatively flexible (Fig. 5c), permitting only the four C-terminal 
residues to be tentatively modeled into the density (Fig. 5d). To compare the C-terminal 
Pro-Pro residues in our structure to other known conformations of Pro-Pro peptides, we 
initially aligned the X-ray structure of a short CCA-Pro-Pro tRNA mimic bound to the 
yeast 80S ribosome35 (Fig. 5e). These two proline residues adopt an all-trans 
conformation, which is present in type II polyproline helices (Fig. 5f), and also observed 
in other diprolyl-containing proteins, such as ribosomal proteins S11 and L1136, and the 
ribosome-bound antimicrobial peptide Onc11237,38 (Supplementary Fig. 6a-c). However, 
this conformation cannot occur on the ribosome because it would produce a steric clash 
between the -2 residue of the nascent chain and nucleotide G2061 of the 23S rRNA that 
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comprises part of the ribosomal exit tunnel (Fig. 5f and Supplementary Fig. 6a-c). 
Similarly, an all-cis conformation of the two prolyl residues is also not compatible with 
the density, nor with translation, since it directs the nascent chain into the ribosomal A-
site (Fig. 5g). Instead, the diprolyl moiety appears to adopt an alternative trans 
conformation, allowing the -2 residue of the nascent chain to bypass G2061 and extend 
into the lumen of the ribosomal tunnel (Fig. 5d). Although higher resolution will be 
required to accurately describe the trans conformation in detail, our model suggests that  
the backbone Psi angle of ~120° is identical with the all-trans conformation, but the Phi 
angle of approximately -90° differs by ~30° from the all-trans Phi angle (-60°). This 
alternative conformation appears to be similar to that observed on the ribosome for the 
diprolyl-containing CMV-stalling peptidyl-tRNA39 (Supplementary Fig. 6d), and the 
overall path of the nascent chain is similar to that observed for other stalling nascent 
polypeptide chains observed on the ribosome, such as TnaC40, VemP41, MifM42, SecM43 
(Supplementary Fig. 6e,f). We suggest the incompatibility between the preferred 
diprolyl conformation of the nascent chain and the ribosome induces a strained 
conformation that can be is relieved either by (i) destabilization of the P-site peptidyl-
tRNA and therefore ribosomal stalling ensues, or (ii) binding of EF-P that stabilizes the 
P-site peptidyl-tRNA and forces the nascent chain to adopt an alternative conformation, 
with the outcome that peptide bond formation can occur. 
 
EF-P stabilizes the P-site tRNA in a pre-attack conformation 
To assess the dynamics of the region surrounding the PTC in the presence of modified 
EF-P, unmodified EF-P or absence of EF-P, we carried out all-atom explicit-solvent 
molecular dynamics (MD) simulations. The first MD simulation was initiated using the 
model of the cryo-EM structure of the NlpD-PP-EF-P-ribosome, and two subsequent 
simulations were performed where either the β-lysine part of modification on K34 or the 
entire EF-P protein were computationally removed. A total of 15 simulations, 2 µs each, 
accumulating to a total simulation run time of 30 µs were performed using a reduced 
system encompassing a 35 Å radius from the PTC. Principal Component Analysis 
(PCA)44 was used to extract the two most dominant conformational modes of motion. As 
shown in Figure 6a, in the presence of modified EF-P, the major conformations are 
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stable and remain close to the cryo-EM structure, which is similar to that observed in the 
X-ray structures of the T. thermophilus pre-attack conformation29 as well as uninduced 
and induced conformations from H. marismortui45. By contrast, after the β -lysine 
modification of EF-P or the complete EF-P protein was removed from the simulation, the 
system explored new conformations, moving away from the conformations observed in 
presence of EF-P, particularly with respect to conformational mode 2 (Fig. 6, c). Since 
conformational mode 2 reflects the relative distance between the α-amino group of an 
aminoacyl-tRNA in the A-site and the carbonyl-carbon of the aminoacyl ester linkage in 
the peptidyl-Pro-Pro-tRNA (Supplementary Fig. 7), the MD simulations suggest that 
when the EF-P modification or the entire EF-P protein was absent, the peptidyl-tRNA 
moved away from the A-site tRNA, generating a geometry that is incompatible with 
peptide bond formation (Fig. 6d, e). By contrast, the presence of the EF-P modification 
stabilized the pre-attack conformation of the P-site tRNA, thus promoting peptide bond 
formation (Fig. 6d). 
 
CONCLUSION 
Collectively, our biochemical and structural findings, together with the available 
literature, lead us to propose a model for polyproline-mediated translational stalling and 
rescue by EF-P (Fig. 7). Ribosomes translating proteins containing polyproline-stretches 
become stalled because of slow peptide bond formation between the peptidyl-Pro-Pro-
tRNA in the P-site and the incoming Pro-tRNA in the A-site5 (Fig. 7a). The favourable 
all-trans conformation of the Pro-Pro peptide is not possible within the context of the 
ribosomal tunnel, which leads to destabilization of the P-site tRNA and nascent chain 
(Fig. 7b). For short oligo-peptidyl-tRNAs, this results in high levels of peptidyl-tRNA 
drop-off5. For longer peptidyl-tRNAs that are more refractory to drop-off, the 
destabilized peptidyl-tRNA results in suboptimal positioning for peptide-bond formation 
and may also disfavour accommodation of the aminoacyl-tRNA at the A-site (Fig. 7b). 
Polyproline-stalled ribosomes are recognized by EF-P, which utilizes features of the E-
site codon of the mRNA as well as specific interactions with D-loop of the P-site Pro-
tRNA31, the L1 stalk and the 30S subunit to promote binding22 (Fig. 7c). While the 
presence of EF-P generally stabilizes the binding of the P-site tRNA, the ε(R)-β-
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lysylhydroxylysine is necessary to specifically interact and stabilize the CCA-end at the 
PTC (Fig. 7d). Stabilization of the CCA-end by the ε(R)-β-lysylhydroxylysine 
modification of EF-P also positions the nascent polypeptide chain such that it extends 
into the lumen of the tunnel (Fig. 7e), thus allowing the CCA-ends of the tRNAs to 
adopted the conformation that favors peptide bond formation (Fig. 7f). It will be 
interesting to see how the distinct modifications found on EF-P in other bacteria, such as 
the rhamnosylation found in P. aeurignosa EF-P18,19 or the 5-aminopentanol moiety of 
B. subtilis EF-P20, stabilize the CCA-end of the P-site tRNA to promote an optimal 
geometry for peptide-bond formation. Moreover, although it remains to be determined as 
to what promotes EF-P dissociation from the ribosome following peptide bond formation, 
our structure suggests that subunit rotation and opening of the L1 stalk are good 
candidates for destabilization of EF-P binding.  
 14 
METHODS (Methods typically do not exceed 3,000 words.) 
Preparation of the E. coli Δefp S12 translation extract 
The E. coli Δefp S12 translation extract was prepared as described for B. subtilis S12 
translation extract42 with some minor modifications. E. coli Δefp cells (Keio collection 
BW25113) were grown to OD600=5.8 in an ‘INFORCE HT minifors’ bench-top 
fermenter in 2xYPTG (16 g/l peptone, 10 g/l yeast extract, 5 g/l NaCl, 22 mM NaH2PO4, 
40 mM Na2HPO4, 19.8 g/l glucose) at 37°C while maintaining pH 7.0 and oxygen level 
(60%). Cells were collected at 5,000 x g at 4°C for 15 min. 22 g of cells were 
resuspended in 14.6 ml of Buffer A (10 mM Tris-acetate, pH 8.2, 14 mM magnesium 
acetate, 60 mM potassium glutamate, 1 mM dithiothreitol and 6 mM 2-mercaptoethanol) 
and broken open in an ‘microfluidics model 110I lab homogenizer’, 3x at 15,000 psi. 
Subsequently, the lysate was cleared at 12,000 x g and incubated for 30 min at 37°C in a 
water bath. The cell extract was aliquoted, snap frozen and stored at -80°C. 
 
PCR and in vitro transcription 
Full-length nlpD-PPP construct with a N-terminal 6 x Histidine-tag was amplified from 
pET-21b-R1nlpD25 using T7 forward (5’-TAATACGACTCACTATAGGG-3’) and T7 
terminator (5’GCTAGTTATTGCTCAGCGG-3’) primer. Truncated nlpD-PP construct 
was amplified from nlpD-PPP PCR product using T7 forward and revPP (5’-
CGGCGGTCTAATCAACATAC-3’) primer. To avoid contamination with remaining 
full-length nlpD-PPP product, nlpD-PP was excised from the agarose gel and a second 
PCR was performed using the excised product as a template with T7 forwards and revPP 
as primers. PCR products were purified and in vitro transcription reaction was performed 
using 2 µg of PCR product per 100 µl reaction volume and T7 RNA polymerase42. The 
RNA was purified by LiCl/ethanol precipitation. 
 
Preparation of full-length NlpD-PPP-SRC and truncated NlpD-PP-SRC 
Full-length NlpD-PPP-SRC was prepared using E. coli Δefp S12 translation extract 
following the procedure described for the B. subtilis MifM-SRC42, except that the volume 
was 2011 µl for the reaction mix and 489 µl of mRNA were added. In vitro translation 
was carried out for 20 min. Translation reaction was stopped by adding ice cold Buffer B 
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(50 mM HEPES pH 7.2 at 4°C, 250 mM KOAc, 10 mM MgOAc, 0,1% DDM, 1/1,000 
complete protease inhibitor (Roche), 0.2 U/ml RNasin). For the truncated NlpD-PP-SRC, 
the in vitro reaction was carried out using PURExpress In Vitro Protein Synthesis Kit 
(NEB #6800). The translation reaction (750 µl in total) was prepared according to the 
protocol of the PURExpress In Vitro Protein Synthesis Kit but was supplemented with 
5 µM anti-ssrA oligo (5’TTAAGCTGCTAAAGCGTAGTTTTCGTCGTTTGCGACTA-
3’). Translation was started by adding the truncated nlpD-PP PCR product and then the 
reaction was incubated at 37°C for 20 min with shaking at 1,000 rpm. The SRCs were 
then purified according to Sohmen et al (2015)42 with some minor modification. The 
SRCs on the Talon metal affinity chromatography column were washed with Buffer B for 
NlpD-PPP-SRC (Dataset 1) or Buffer C (same as Buffer B but with 500 mM KOAc 
instead of 250 mM KOAc), for Dataset 2 and 3.  
 
Generation and purification of modified EF-P and mutants 
Modified active EF-P was purified as described16. All EF-P variants were generated by 
site-directed mutagenesis PCR, similarly as described for TetM variants by Arenz et al 
(2015)46. The EF-P variants were overexpressed in E. coli BL21 cells grown at 37°C 
from overnight culture in lysogeny broth (LB) medium and in the presence of 100 µg/mL 
ampicillin. Protein expression was induced at an OD600 of 0.4 with a final concentration 
of 1 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) (Roth). Proteins were expressed 
from pET-plasmids (listed in Supplementary Table 1). To ensure post-translational 
modification, the EF-P variants were co-expressed with YjeA and YjeK from pRSFDuet 
vector. After 1 hour of expression cells were lysed using a microfluidizer. The cell lysate 
was cleared using a SS34 rotor at 4°C and 44,100 x g for 30 minutes. Purification of His-
tagged proteins was done with Protino Ni-NTA agarose beads (Macherey-Nagel). The 
final eluate was applied onto a Superdex HiLoad S75 16/600 column (GE Healthcare) to 
yield the final concentrated protein in gel filtration buffer (50 mM HEPES pH 7.4, 50 
mM KCl, 100 mM NaCl and 5 mM 2-mercaptoethanol).  
 
Luminescence determination of firefly luciferase 
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In vitro translation of the firefly luciferase was performed using the PURExpress in vitro 
translation kit. For template generation Fluc3xPro was amplified via PCR using T7 
forward and T7 reverse primer (Supplementary Table 2) from plasmid pIVEX-
Fluc3xPro7. Samples have been incubated at 37°C for defined time periods. 1 µl of each 
reaction were added on to white 96-well chimney flat bottom microtiter plates. 40 µl of 
luminol substrate (Promega) were added, immediately before luminescence was detected 
using a Tecan Infinite M1000. 
 
Negative-stain electron microscopy 
Ribosomal particles were diluted in Buffer B to final concentrations of 4.0 A260/ml up to 
5.0 A260/ml in order to determine the optimal ribosome density for cryo-EM. Samples 
were stained according with uranyl acetate. Micrographs were taken using a Morgagni 
transmission electron microscope (FEI), 80 kV, wide angle 1K CCD at direct 
magnifications of 72K. 
 
Cryogrid preparation for the NlpD-PPP-SRC and NlpD-PP-SRC 
Dataset 1: For grid preparation 4.5 OD A260/ml monosomes of the full-length NlpD-PPP-
SRC were used. Dataset 2: For grid preparation 5.0 OD A260/ml monosomes of the full 
length NlpD-PPP-SRC were used and a 3x excess of modified EF-P over 70S was added 
and incubated for 20 mins at 37°C. Dataset 3: For grid preparation 4.5 OD A260/ml 
monosomes of the truncated NlpD-PP SRC were used. A 5x excess of modified EF-P 
over 70S as well as 100 µM evernimicin (to ensure absence of A-site tRNA47) were 
added and incubated for 5 mins at 37°C. All samples were applied to 2 nm precoated 
Quantifoil R3/3 holey carbon supported grids and vitrified using a Vitrobot Mark IV (FEI 
company). 
 
Ribosome complexes for kinetic experiments 
The mRNA GGGCAAGGAGGUAAAUAAUGCCGCCGCCGUUCAUU) coding for 
fMPPPF was synthesized by IBA Lifescience. Initiation complexes were formed by 
incubating 70S ribosomes (1 µM) with IF 1, IF2, IF3 (1.5 µM each), f[3H]Met-tRNAfMet 
(3 µM) and GTP (1 mM) in buffer D (50 mM Tris-HCl, pH 7.5 at 37°C, 70 mM NH4Cl, 
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30 mM KCl and 7 mM MgCl2 ) for 30 min5. Initiation complexes were purified by 
centrifugation through a 400 µl sucrose cushion (40% sucrose in buffer D) at 260,000 g 
for 2 h at 4°C. Pellets were dissolved in buffer D, flash frozen and stored at -80°C. 
[14C]Phe-tRNAPhe was prepared from total tRNA as described. tRNAPro in-vitro 
transcripts were prepared and aminoacylated as described5. Ternary complexes EF-Tu–
GTP–aminoacyl-tRNA were prepared by incubating aminoacyl-tRNA (Pro-tRNAPro and 
Phe-tRNAPhe) with a 2.5-fold excess of EF-Tu, GTP (1 mM), pyruvate kinase (0.1 µg/µl) 
and phosphoenolpyruvate (3 mM) for 15 min at 37°C.  
 
In vitro translation of fMPPPF model peptide 
Initiation complexes (0.2 µM), ternary complexes Pro and Phe (each 2 µM), EF-G (1 
µM) and EF-P (varying concentrations) were mixed in buffer E (50 mM Tris-HCl, pH 7.5 
at 37°C, 70 mM NH4Cl, 30 mM KCl, 3.5 mM MgCl2, 0.5 mM spermidine, 8 mM 
putrescine and 2 mM DTT) at 37°C. The reaction was quenched after 20 s with KOH (0.5 
M), hydrolyzed for 30 min at 37°C and neutralized with glacial acetic acid. Amino acids 
and peptides were separated by reversed-phase HPLC (Chromolith® Performance RP8e 
100-4.6 column, Merck) using a 0-65% acetonitrile gradient in 0.1% TFA. Products and 
educts were quantified by double-label scintillation counting5.  
 
Molecular Dynamics Simulations 
To obtain the dynamics of the region surrounding the peptdidyl transferase center (PTC) 
in presence of EF-P, unmodified EF-P or without EF-P, we carried out all-atom explicit-
solvent molecular dynamics (MD) simulations. The simulations were started (i) from the 
cryo-EM structure, (ii) from the cryo-EM structure after removal of the β -lysine 
modification of Lys34 (EF-P), and (iii) after removal of EF-P. Since the structural 
differences between the cryo-EM structures with and without EF-P are only found in the 
vicinity of the PTC, we used a reduced simulation system that allowed us to increase the 
achievable simulation time. The simulation system (+EF-P) includes all residues of the 
cryo-EM structure located within 35 Å of any atom of the P-site tRNA CCA-tail, of the 
attached peptide, or of the β-lysine modified Lys34 of EF-P. Nucleotides (amino acids) 
that are not within this radius, but whose 5’- and 3’- (n- and c-) neighbors are within the 
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radius, are also included in the simulation system. Nucleotides whose 5’ (3’) bound 
nucleotide neighbor is not in the simulation system were treated as 5’ (3’) terminal 
nucleotides. Any amino acid i whose i−1 neighbor (i + 1 neighbor) is not in the 
simulation system was capped by an uncharged N-terminal acetyl (C-terminal amide). 
Positions of residues in a 25 Å radius were not restrained (inner layer), while heavy atom 
positions the remaining residues (outer layer) were restrained by a harmonic potential. 
The harmonic force constant k of each restrained atom was chosen as k = 8RT πrmsf2 
where rmsf is the root mean square fluctuation of the corresponding atom obtained from a 
2 µs-simulations of the full ribosome in complex with A- and P-site tRNAs and the 
ErmBL peptide28. For those heavy atoms without corresponding atoms in the full-ribsome 
simulations, the average of all other force constants was used. Two more simulation 
systems were used, one after removal of the modification of EF-P Lys34 (+EF-P 
(unmod)) and the other after removal of all EF-P atoms (–EF-P). To place initial Mg ions, 
a cryo-EM structure of the ribosome36 was aligned to each simulation system. Then, Mg 
ions resolved in the cryo-EM structure that are located within 5 Å of the atoms of the 
simulation system were extracted from the aligned structure and included in the 
simulations system. WHATIF48 was used to determine the protonation states of the 
histidines. Each simulation systems was then solvated in a dodecahedron box of water 
molecules with a minimum distance of 1.5 nm between the atoms of the simulation 
system and the box boundaries using the program solvate49. To neutralize the overall 
charge of each system, first the Coulomb potential at the positions of all water oxygen 
atoms was calculated based on the charges and positions of all other atoms. Iteratively, 
the water molecule with the lowest Coulomb potential was replaced by a K+ ion and the 
Coulomb potential at all other water oxygens was updated until the overall charge was 
neutral. Using the program GENION49, subsequently 7 mM MgCl2 and 150 mM KCl 
were added. All simulations were carried out with Gromacs 549  using the amberﬀ12sb 
force field50 and the SPC/E water model51. Force field parameters for modified 
nucleotides were taken from Aduri et al52. Potassium and chloride ion parameters were 
taken from Joung and Cheatham53. Atom types for β-lysine modified Lys were obtained 
with ANTECHAMBER54 and partial charges were determined using DFT-B3LYP with a 
6-31/G* basis set. The ester bond between the c-terminal proline and A76 of the P-site 
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tRNA was treated as described earlier55. LennardJones and short-range Coulomb 
interactions were calculated within a distance of 1 nm, while long-range Coulomb 
interactions were calculated using particle-mesh Ewald summation56. The LINCS 
algorithm was used to constrain bond lengths57 and virtual site constraints58 were used for 
hydrogens, allowing an integration time step of 4 fs. Solute and solvent temperatures 
were controlled independently at 300 K using velocity rescaling59 with a coupling time 
constant of 0.1 ps. For each of the three simulation systems, the system was equilibrated 
in four steps. First, the potential energy was minimized using steepest decent while 
restraining the positions of all solute heavy atoms (k = 1000 kJ mol−1 nm−2). Second, for 
the first 50 ns, the pressure was coupled to a Berendsen barostat (1 ps coupling time)60 
and position restraints were applied. Third, during the next 20 ns, the position restraint 
force constant was linearly decreased to the values obtained from the full-ribosome 
simulations for the outer-layer atoms and to zero for the remaining atoms. Finally, for 
production runs starting at 70 ns, the Parrinello-Rahman barostat was used61. At 
simulation times 170, 270, 370, and 470 ns coordinates were extracted from the trajectory, 
new velocities were assigned according to a Boltzmann distribution, and subsequently 
new simulations were started, resulting in a total of 15 simulations, 2 µs each, 
accumulating to a total production run simulation time of 30 µs. 
 
Conformational landscape of CCA-end and C-terminal proline 
To investigate how either the removal of the modification of EF-P or the removal of EF-P 
entirely changes the conformation of the P-site CCA-tail and the C-terminal proline of 
the peptide, we carried out a Principal Component Analysis (PCA)44. A PCA is used to 
extract the dominant modes of motion, here the first two eigenvectors. To that aim, we 
first aligned all the trajectories using all 23S P atoms and, second, extracted backbone 
atoms of the CCA-tail (O3’, C3’, C4’, C5’, O5’, and P atoms) and of the peptide (N, CA, 
C, and O atoms). The extracted trajectories were then concatenated and the atomic 
displacement covariance matrix was calculated. The eigenvectors of this covariance 
matrix were sorted according to their eigenvalues. The eigenvectors corresponding to the 
largest eigenvalues represent the most dominant conformational modes. To describe the 
structural ensembles obtained from the three sets of simulations, first, the projection of all 
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the frames onto the first two eigenvectors was calculated. For each set of simulations, the 
projections were then sorted into 2-dimensional bins and the logarithm of the probability 
ρ = c_i,j/c_total of each bin i,j was calculated, where c_i,j is the number of the 
projections in the bin, c_total is the total number of frames (Fig. 6a-c). For comparison, 
our cryo-EM structure with EF-P as well the X-ray structures of the pre-attack 
conformation29 and the uninduced and induced conformations45 were projected onto the 
two conformational modes (Fig. 6a-c). For each set of simulations, all the structures 
sorted into the bin marked with a cross in the conformational landscape (Fig. 6a-c) were 
extracted. For each set, from the extracted structures the one with the median peptide 
bond distance was chosen and is shown in (Fig. 6d-f).  
 
Cryo-electron microscopy and single particle reconstruction 
Data collection were performed on FEI Titan Krios transmission electron microscopes 
equipped with a Falcon II direct electron detector (FEI) at 300 kV at a pixel size of 1.064 
Å (Dataset 1) or 1.084 Å (Dataset 2 and 3). Dataset 1: Defocus range was from -1.0 to -
2.5 µm (underfocus) resulting in 1156 Micrographs after manual inspection and 
discarding micrographs with resolution worse than 4 Å. Each micrograph contained 16 
frames (2.68 e-/ Å 2). Original image stacks were motion-corrected and dose weighted 
using MotionCor262. Dataset 2 and 3: Defocus range was from -0.8 to -2.5 µm 
(underfocus) resulting in 2109 micrographs for Dataset 2 and 1957 micrographs for 
Dataset 3 after manual inspection and discarding micrographs showing a resolution worse 
than 3.3 Å (Dataset 2) and 3.4 Å (Dataset 3), respectively. Each micrograph contained 17 
frames in total (2.4 e-/ Å2 + 4 e-/ Å2 pre exposure) and frames 0-9 were used resulting in a 
total dose of 28 e-/ Å2. Original image stacks were motion-corrected using MotionCor262. 
Power-spectra, defocus values, astigmatism and estimation of resolution were determined 
using CTFFIND4 software63. 
After automated particle picking using SIGNATURE64 single particles were 
processed using RELION-265. All particles from the three datasets (Dataset 1: 121,704 
particles, Dataset 2: 229,613 particles, Dataset 3: 229,458 particles) were first subjected 
to 3D refinement using an E. coli 70S ribosome as reference structure and subsequently a 
3D classification was performed (Supplementary Fig. 1). Dataset 1 was classified into 
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four classes and dataset 2 and 3 into eight classes. For dataset 3 classes 2 and 3 were 
joined and a second classification was performed with a mask focusing on EF-P. Final 
structures of all datasets were refined, corrected for the modulation transfer function of 
the Falcon 2 detector and sharpened by applying a negative B-factor automatically 
estimated by RELION-2 (Table 1). Resolution was estimated using the “gold standard” 
criterion (FSC=0.143). 
 
Molecular modeling and map-docking procedures 
The molecular model for the ribosomal proteins and rRNA of either the PPP or PP stalled 
complexes is based on the molecular model for the 70S subunit from the cryo-EM 
reconstruction of the E. coli 70S ribosome (PDB ID 5AFI)36 and obtained by performing 
a rigid body fit into the cryo-EM density map of the corresponding stalled complex using 
UCSF Chimera66 (fit in map function). For E. coli EF-P, a homology model was 
generated using HHPred67 based on a template from T. thermophilus (PDB ID 3HUW)22. 
The model was fitted to the density using Chimera66 and refined in Coot68. The post-
translational modification of ε(R)−β−lysyl-hydroxylysine that is positioned at K34 of EF-
P was designed using Chem3DPro (PerkinElmer), manually placed into the cryo-EM 
density map at position 34 of EF-P and refined in Coot. P-site tRNA of the E. coli 70S 
ribosome (PDB ID 5AFI)36 was manually mutated to tRNAPro(CCG). In the case of the 
truncated PP-SRC in the presence of EF-P, the L1 stalk and L1 protein were taken from 
the crystal structure of T. thermophilus (PDB ID 3HUW), manually mutated and refined 
using Coot. Nucleotides of the PTC that differ from the cryo-EM E. coli 70S ribosome 
(PDB ID 5AFI)36 were manually refined into density using Coot. Atomic coordinates 
were refined using phenix.real_space_refine,69 with restraints obtained by 
phenix.secondary_structure_restraints.69 Cross-validation against overfitting was 
performed as described elsewhere70. Statistics of the refined models were obtained using 
MolProbity71 and are presented in Table 1. 
 
Figure preparation 
Figures showing electron densities and atomic models were generated using either UCSF 
Chimera or PyMol Molecular Graphic Systems (Version 1.8 Schrödinger). 
 22 
REFERENCES (up to 60 references) 
1. Pavlov, M.Y. et al. Slow peptide bond formation by proline and other N-
alkylamino acids in translation. Proc Natl Acad Sci U S A 106, 50-4 (2009). 
2. Johansson, M. et al. pH-sensitivity of the ribosomal peptidyl transfer reaction 
dependent on the identity of the A-site aminoacyl-tRNA. Proc. Natl Acad. Sci. 
USA 108, 79-84 (2011). 
3. Muto, H. & Ito, K. Peptidyl-prolyl-tRNA at the ribosomal P-site reacts poorly 
with puromycin. Biochem. Biophys. Res. Commun. 366, 1043-7 (2008). 
4. Wohlgemuth, I., Brenner, S., Beringer, M. & Rodnina, M.V. Modulation of the 
rate of peptidyl transfer on the ribosome by the nature of substrates. J. Biol. Chem. 
283, 32229-35 (2008). 
5. Doerfel, L.K. et al. EF-P is essential for rapid synthesis of proteins containing 
consecutive proline residues. Science 339, 85-8 (2013). 
6. Doerfel, L.K. et al. Entropic Contribution of Elongation Factor P to Proline 
Positioning at the Catalytic Center of the Ribosome. J Am Chem Soc 137, 12997-
3006 (2015). 
7. Ude, S. et al. Translation elongation factor EF-P alleviates ribosome stalling at 
polyproline stretches. Science 339, 82-5 (2013). 
8. Woolstenhulme, C.J. et al. Nascent peptides that block protein synthesis in 
bacteria. Proc Natl Acad Sci U S A 110, E878-87 (2013). 
9. Gutierrez, E. et al. eIF5A promotes translation of polyproline motifs. Mol Cell 51, 
35-45 (2013). 
10. Dever, T.E., Gutierrez, E. & Shin, B.S. The hypusine-containing translation factor 
eIF5A. Crit Rev Biochem Mol Biol, 1-13 (2014). 
11. Lassak, J., Wilson, D.N. & Jung, K. Stall no more at polyproline stretches with 
the translation elongation factors EF-P and IF-5A. Mol Microbiol (2015). 
12. Peil, L. et al. Distinct XPPX sequence motifs induce ribosome stalling, which is 
rescued by the translation elongation factor EF-P. Proc Natl Acad Sci U S A 110, 
15265-70 (2013). 
13. Behshad, E. et al. Enantiomeric free radicals and enzymatic control of 
stereochemistry in a radical mechanism: the case of lysine 2,3-aminomutases. 
Biochemistry 45, 12639-46 (2006). 
14. Yanagisawa, T., Sumida, T., Ishii, R., Takemoto, C. & Yokoyama, S. A paralog 
of lysyl-tRNA synthetase aminoacylates a conserved lysine residue in translation 
elongation factor P. Nat. Struct. Mol. Biol. 17, 1136-43 (2010). 
15. Navarre, W.W. et al. PoxA, yjeK, and elongation factor P coordinately modulate 
virulence and drug resistance in Salmonella enterica. Mol. Cell 39, 209-221 
(2010). 
16. Peil, L. et al. Lys34 of translation elongation factor EF-P is hydroxylated by 
YfcM. Nat. Chem. Biol. 8, 695-7 (2012). 
17. Bailly, M. & de Crecy-Lagard, V. Predicting the pathway involved in post-
translational modification of elongation factor P in a subset of bacterial species. 
Biol. Direct 5, 3 (2010). 
18. Lassak, J. et al. Arginine-rhamnosylation as new strategy to activate translation 
elongation factor P. Nat Chem Biol 11, 266-70 (2015). 
 23 
19. Rajkovic, A. et al. Cyclic Rhamnosylated Elongation Factor P Establishes 
Antibiotic Resistance in Pseudomonas aeruginosa. MBio 6, e00823 (2015). 
20. Rajkovic, A. et al. Translation Control of Swarming Proficiency in Bacillus 
subtilis by 5-Amino-pentanolylated Elongation Factor P. J Biol Chem 291, 10976-
85 (2016). 
21. Hanawa-Suetsugu, K. et al. Crystal structure of elongation factor P from Thermus 
thermophilus HB8. Proc. Natl Acad. Sci. U S A 101, 9595-9600 (2004). 
22. Blaha, G., Stanley, R.E. & Steitz, T.A. Formation of the first peptide bond: the 
structure of EF-P bound to the 70S ribosome. Science 325, 966-70 (2009). 
23. Melnikov, S. et al. Crystal Structure of Hypusine-Containing Translation Factor 
eIF5A Bound to a Rotated Eukaryotic Ribosome. J Mol Biol 428, 3570-3576 
(2016). 
24. Schmidt, C. et al. Structure of the hypusinylated eukaryotic translation factor eIF-
5A bound to the ribosome. Nucleic Acids Res 44, 1944-51 (2016). 
25. Starosta, A.L. et al. Translational stalling at polyproline stretches is modulated by 
the sequence context upstream of the stall site. Nucleic Acids Res 42, 10711-9 
(2014). 
26. Arenz, S. et al. Drug Sensing by the Ribosome Induces Translational Arrest via 
Active Site Perturbation. Mol Cell 56, 446-52 (2014). 
27. Arenz, S. et al. Molecular basis for erythromycin-dependent ribosome stalling 
during translation of the ErmBL leader peptide. Nat Commun 5, 3501 (2014). 
28. Arenz, S. et al. A combined cryo-EM and molecular dynamics approach reveals 
the mechanism of ErmBL-mediated translation arrest. Nature communications 7, 
12026 (2016). 
29. Polikanov, Y.S., Steitz, T.A. & Innis, C.A. A proton wire to couple aminoacyl-
tRNA accommodation and peptide-bond formation on the ribosome. Nat Struct 
Mol Biol 21, 787-93 (2014). 
30. Voorhees, R.M., Weixlbaumer, A., Loakes, D., Kelley, A.C. & Ramakrishnan, V. 
Insights into substrate stabilization from snapshots of the peptidyl transferase 
center of the intact 70S ribosome. Nat Struct Mol Biol 16, 528-533 (2009). 
31. Katoh, T., Wohlgemuth, I., Nagano, M., Rodnina, M.V. & Suga, H. Essential 
structural elements in tRNA(Pro) for EF-P-mediated alleviation of translation 
stalling. Nat Commun 7, 11657 (2016). 
32. Schuller, A.P., Wu, C.C., Dever, T.E., Buskirk, A.R. & Green, R. eIF5A 
Functions Globally in Translation Elongation and Termination. Mol Cell 66, 194-
205 e5 (2017). 
33. Pelechano, V. & Alepuz, P. eIF5A facilitates translation termination globally and 
promotes the elongation of many non polyproline-specific tripeptide sequences. 
Nucleic Acids Res (2017). 
34. Zhou, J., Korostelev, A., Lancaster, L. & Noller, H.F. Crystal structures of 70S 
ribosomes bound to release factors RF1, RF2 and RF3. Curr Opin Struct Biol 22, 
733-42 (2012). 
35. Melnikov, S. et al. Molecular insights into protein synthesis with proline residues. 
EMBO Rep 17, 1776-1784 (2016). 
36. Fischer, N. et al. Structure of the E. coli ribosome-EF-Tu complex at <3 A 
resolution by C-corrected cryo-EM. Nature 520, 567-570 (2015). 
 24 
37. Seefeldt, A.C. et al. The proline-rich antimicrobial peptide Onc112 inhibits 
translation by blocking and destabilizing the initiation complex. Nat Struct Mol 
Biol 22, 470-5 (2015). 
38. Roy, R.N., Lomakin, I.B., Gagnon, M.G. & Steitz, T.A. The mechanism of 
inhibition of protein synthesis by the proline-rich peptide oncocin. Nat Struct Mol 
Biol 22, 466-9 (2015). 
39. Matheisl, S., Berninghausen, O., Becker, T. & Beckmann, R. Structure of a 
human translation termination complex. Nucleic acids Res. 43, 8615-26 (2015). 
40. Bischoff, L., Berninghausen, O. & Beckmann, R. Molecular basis for the 
ribosome functioning as an L-tryptophan sensor. Cell Rep 9, 469-75 (2014). 
41. Su, T. et al. The force-sensing peptide VemP employs extreme compaction and 
secondary structure formation to induce ribosomal stalling. Elife 6(2017). 
42. Sohmen, D. et al. Structure of the Bacillus subtilis 70S ribosome reveals the basis 
for species-specific stalling. Nat Commun 6, 6941 (2015). 
43. Zhang, J. et al. Mechanisms of ribosome stalling by SecM at multiple elongation 
steps. eLife 4(2015). 
44. Amadei, A., Linssen, A.B. & Berendsen, H.J. Essential dynamics of proteins. 
Proteins 17, 412-25 (1993). 
45. Schmeing, T.M., Huang, K.S., Strobel, S.A. & Steitz, T.A. An induced-fit 
mechanism to promote peptide bond formation and exclude hydrolysis of 
peptidyl-tRNA. Nature 438, 520-524 (2005). 
46. Arenz, S., Nguyen, F., Beckmann, R. & Wilson, D.N. Cryo-EM structure of the 
tetracycline resistance protein TetM in complex with a translating ribosome at 
3.9-A resolution. Proc Natl Acad Sci U S A 112, 5401-6 (2015). 
47. Arenz, S. et al. Structures of the orthosomycin antibiotics avilamycin and 
evernimicin in complex with the bacterial 70S ribosome. Proc Natl Acad Sci U S 
A 113, 7527-32 (2016). 
48. Vriend, G. WHAT IF: a molecular modeling and drug design program. J Mol 
Graph 8, 52-6, 29 (1990). 
49. Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open 
source molecular simulation toolkit. Bioinformatics 29, 845-54 (2013). 
50. Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber 
ff99SB protein force field. Proteins 78, 1950-8 (2010). 
51. Berendsen, H.J.C., Grigera, J.R. & Straatsma, T.P. The missing term in effective 
pair potentials. J. Phys. Chem. 91, 6269–6271 (1987). 
52. Aduri, R. et al. AMBER Force Field Parameters for the Naturally Occurring 
Modified Nucleosides in RNA. J Chem Theory Comput 3, 1464-75 (2007). 
53. Joung, I.S. & Cheatham, T.E., 3rd. Determination of alkali and halide monovalent 
ion parameters for use in explicitly solvated biomolecular simulations. J Phys 
Chem B 112, 9020-41 (2008). 
54. Wang, J., Wang, W., Kollman, P.A. & Case, D.A. Automatic atom type and bond 
type perception in molecular mechanical calculations. J Mol Graph Model 25, 
247-60 (2006). 
55. Bock, L.V. et al. Energy barriers and driving forces in tRNA translocation 
through the ribosome. Nat Struct Mol Biol 20, 1390-6 (2013). 
 25 
56. Essmann, U. et al. A smooth particle mesh ewald method. J. Chem. Phys. 103, 
8577–8593 (1995). 
57. Hess, B. P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation. 
J Chem Theory Comput 4, 116-22 (2008). 
58. Feenstra, K.A., Hess, B. & Berendsen, H.J.C. Improving efficiency of large time-
scale molecular dynamics simulations of hydrogen-rich systems. J. Comput. 
Chem. 20, 786–798 (1999). 
59. Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity 
rescaling. J Chem Phys 126, 014101 (2007). 
60. Berendsen, H.J.C., Postma, J.P.M., van Gunsteren, W.F., DiNola, A. & Haak, J.R. 
Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81(1984). 
61. Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: A new 
molecular dynamics method. J. Appl. Phys. 52(1981). 
62. Zheng, S.Q. et al. MotionCor2: anisotropic correction of beam-induced motion for 
improved cryo-electron microscopy. Nat Methods 14, 331-332 (2017). 
63. Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation 
from electron micrographs. J Struct Biol 192, 216-21 (2015). 
64. Chen, J.Z. & Grigorieff, N. SIGNATURE: a single-particle selection system for 
molecular electron microscopy. J. Struct. Biol. 157, 168-73 (2007). 
65. Scheres, S.H. RELION: implementation of a Bayesian approach to cryo-EM 
structure determination. J Struct Biol 180, 519-30 (2012). 
66. Pettersen, E.F. et al. UCSF Chimera - A Visualization System for Exploratory 
Research and Analysis. J. Comput. Chem. 25, 1605-1612 (2004). 
67. Hildebrand, A., Remmert, M., Biegert, A. & Soding, J. Fast and accurate 
automatic structure prediction with HHpred. Proteins 77 Suppl 9, 128-132 (2009). 
68. Emsley, P. & Cowtan, K. Coot: Model-Building Tools for Molecular Graphics. 
Acta Crystallographica Section D - Biological Crystallography 60, 2126-2132 
(2004). 
69. Adams, P.D. et al. PHENIX: a comprehensive Python-based system for 
macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-
21 (2010). 
70. Brown, A. et al. Tools for macromolecular model building and refinement into 
electron cryo-microscopy reconstructions. Acta Crystallogr D Biol Crystallogr 71, 
136-53 (2015). 
71. Chen, V.B. et al. MolProbity: all-atom structure validation for macromolecular 
crystallography. Acta Crystallogr D Biol Crystallogr 66, 12-21 (2010). 
 26 
 
ACKNOWLEDGMENTS 
We thank Susanne Rieder and Olaf Geintzer for expert technical assistance and Bertrand 
Beckert for helpful comments. This research was supported by iNEXT project 1503 (to 
D.N.W.) and grants of the Forschergruppe FOR1805 (to A.V., D.N.W., H.G, I.W, M.V.R 
and R.B.) from the Deutsche Forschungsgemeinschaft (DFG). 
 
AUTHOR CONTRIBUTIONS 
P.H., S.A., M.G., A.H., J.N., O.B., R.B., D.N.W. performed cryo-EM analysis, P.H. 
performed Fluc assays, P.H., M.G., L.P., A.L.S, T.T. prepared active EF-P proteins, J.O.F, 
I.W., F.P., M.V.R. performed peptide synthesis assays, L.V.B., H.G., A.C.V. performed 
molecular dynamic simulations. P.H. and D.N.W. prepared the figures and wrote the 
paper with help from I.W., L.V.B, A.C.V., and M.V.R. 
 
COMPETING FINANCIAL INTERESTS 
The authors declare no competing financial interests. 
 
ACCESSION NUMBERS 
The cryo-EM maps and associated atomic coordinates have been deposited in the EMDB 
and PDB with the accession codes EMDB-XYZ/PDB-XYZ (Dataset 1, P-site tRNA only), 
EMDB-XYZ/PDB-XYZ (Dataset 1, A- and P-site tRNAs), EMDB-XYZ/PDB-XYZ 
(Dataset 2, P-site tRNA only), EMDB-XYZ/PDB-XYZ (Dataset 2, A- and P-site tRNA 
and EF-P), EMDB-XYZ/PDB-XYZ (Dataset 3, P- and E-site tRNAs), EMDB-
XYZ/PDB-XYZ (Dataset 3, P-site tRNA and EF-P). 
 27 
FIGURES (Figure legends should be <300 words each.) 
Figure 1 Cryo-EM structures of polyproline-stalled ribosomes in the absence of EF-P. 
(a) Schematic representation of NlpD-PPP reporter protein (brown) with the site of the 
PPP-motif indicated. Western blot using an anti-HA-tag antibody of in vitro translation 
reactions of NlpD-PPP reporter in the absence (-) and presence (+) of EF-P. Full-length 
(FL), peptidyl-tRNA and free peptide, as well as loading control (LC) are indicated. (b) 
Schematic representation and (c-d) cryo-EM reconstructions of PPP-stalled ribosome 
complexes formed in the absence of EF-P. (e,f) Cryo-EM density at high threshold (7σ), 
colored according to the local resolution, for the P-site tRNA (grey ribbon) from cryo-
EM maps in (c) and (d), respectively. (g) Cryo-EM density (mesh) of the CCA-end of the 
P-site tRNA (green) from (c), with modeled fMet (cyan, PDB ID 1VY4)29 illustrating 
lack of density for nascent chain even at low thresholds (4σ). (h) Cryo-EM density 
(mesh) of the CCA-end of the A-site tRNA (orange) and P-site tRNA (green) from (d), 
with modeled Phe (green) and fMet (cyan, PDB ID 1VY4)29.  
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Figure 2 Cryo-EM structures of polyproline-stalled ribosomes in the presence of EF-P. 
(a) Schematic representation and (b,c) cryo-EM reconstructions of PPP-stalled ribosome 
complexes with (b) or without (c) of EF-P (salmon) bound in the E-site. (d,e) Cryo-EM 
density (mesh) of the CCA-end of the P-site tRNA (green) from (c) and (b), respectively, 
with modeled fMet (cyan, PDB ID 1VY4)29. (f) Cryo-EM density (mesh) of the CCA-end 
of the A-site tRNA (orange) and P-site tRNA (green) from (b), with modeled fMet-Phe 
dipeptide (green, PDB ID 1VY5)29. (g) Cryo-EM density (mesh) for the N-terminal 
residues of L27 (purple) showing possible interactions with residues G2251 and G2252 
of the P-loop (grey) and A-site tRNA (orange). 
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Figure 3 Stabilization of the P-site peptidyl-tRNA by EF-P. (a) Schematic representation 
and (b,c) cryo-EM reconstructions of truncated NlpD-PP-stalled ribosomes in the 
presence (b) or absence (c) of EF-P (salmon). (d-f) Cryo-EM densities colored according 
to local resolution for the P-site tRNAs from (d,e) reconstructions illustrated in (b,c), 
respectively, as well as from (f) the reconstruction from Fig. 2c. 
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Figure 4 Interaction of EF-P with the P-site tRNA. (a) Cryo-EM density (mesh) with 
molecular model for EF-P (salmon ribbon) with domains 1-3 (d1-d3) indicated. (b) 
Overview of EF-P relative to P-site bound tRNAPro (green) with a zoom on the 
interactions between Y183 and R186 of EF-P and their respective interaction partners of 
tRNAPro and h29 (blue) of the 30S subunit. (c) Luminescence resulting from in vitro 
translated Fluc-3xPro was monitored over time and quantified in the absence of EF-P 
(red) or presence of wildtype EF-P (pink) or indicated EF-P variants. 100% luminescence 
is defined as the luminescence produced by Fluc-3xPro after a 30-min incubation in the 
presence of wildtype EF-P. Error bars represent the standard deviation of three 
independent experiments. (d) Location of EF-P d3 loop I relative to peptidyl-tRNAPro 
(green) in the P-site, mRNA (light blue) and ribosomal protein S7 (cyan), with the 
position of the loop of S7 in the absence of EF-P (tan) indicated for reference. The 
relative position of T. thermophilus EF-P22 (grey) is shown with the disordered region of 
d3 loop of EF-P indicated (dashed line). The positions of the conserved residues within 
the 144GDT146 motif within loop I of EF-P are indicated by spheres. (e) Potential 
hydrogen-bond interactions (dashed yellow lines) between Loop I of EF-P (salmon), the 
E-site codon (blue) and S7 (cyan). (f) Synthesis of the fMPPPF peptide as a function of 
EF-P concentration, in the presence of wildtype EF-P (pink) or various EF-P variants. 
Error bars represent the standard deviation of three independent experiments. 
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Figure 5 EF-P stabilizes the PP-containing nascent chain. (a) Cryo-EM density (grey 
mesh) for the CCA-end of the P-site tRNA (green) and ε(R)-β-lysyl-hydroxylysine 
modification of EF-P (salmon). (b) Same as (a), but without cryo-EM density, and 
potential hydrogen bond interactions (dashed lines) between the ε(R)-β-lysyl-
hydroxylysine modification, P-site tRNA (green) and A2439 (grey) are indicated. (c) 
Cryo-EM density colored according to the local resolution for the CCA-end of the P-site 
tRNA, ε(R)-β-lysyl-hydroxylysine modification of EF-P and the modeled nascent chain 
(Pro1-Pro2-Ala3-Ala4). (d-g) Cryo-EM density (mesh) for the P-site tRNA with (d) the 
first four residues of the modeled nascent chain (NC) Pro1-Pro2-Ala3-Ala4 (cyan), (e) 
all-trans Pro-Pro conformation of CCA-Pro-Pro tRNA mimic in complex with yeast 80S 
ribosome (PDB ID 5DGV)35, (f) three prolines of a polyproline type II (PII) helix (PP-
trans) modeled onto CCA-end of the P-site tRNA, with G2061 shown as a surface to 
better illustrate the steric clash with the PP-trans nascent chain, (g) three prolines of a 
polyproline type I (PI) helix (PP-cis) modeled onto CCA-end of the P-site tRNA, showing 
a potential clash with a Pro residue (light green surface) attached to the A-site tRNA 
(orange). 
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Figure 6 MD simulations of polyproline-stalled ribosomes in the presence and absence of 
EF-P. (a-c) Conformational landscape explored by MD simulations with (a) EF-P, (b) 
without EF-P, or (c) with unmodified EF-P. The logarithm of the probability density ρ is 
shown along the two most dominant conformational modes of the CCA-end and the C-
terminal proline backbone atoms. Probability density maxima are indicated by crosses, 
green (simulations with EF-P), red (without EF-P) and blue (unmodified EF-P). For 
comparison, + signs indicate the projections of our cryo-EM derived structure (black), the 
pre-attack state29 (grey), the uninduced and the induced states45 (cyan and magenta, 
respectively). (d-f) Conformations of P-site tRNA with peptide and EF-P corresponding 
to the density maxima obtained from MD simulations (d) with EF-P (green), (e) without 
EF-P (red) and (f) with unmodified EF-P (blue). The cryo-EM structure with EF-P 
(black) and the pre-attack29 (grey) conformation are shown for comparison. 
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Figure 7 Mechanism of action of EF-P on polyproline stalled ribosomes. (a) 
Ribosomes stall during translation of proteins containing three consecutive prolines5,7 
leading to destabilization of the peptidyl-tRNA in the P-site, which (b) leads to peptidyl-
tRNA drop-off, particular with short peptidyl-tRNAs5. (c) The all-trans or all-cis 
conformation of polyprolines (red stars) of the nascent chain is not possible because of a 
steric clash with G2061 (grey) within the tunnel wall, leading to peptidyl-tRNA 
destabilization and thus preventing accommodation of the A-site tRNA and peptide bond 
formation. (d) Ribosomes stalled on polyproline stretches are recognized by EF-P, which 
binds within the E-site region and stabilizes the peptidyl-tRNA. EF-P binding is 
facilitated via contacts with the L1 stalk22 and the P-site tRNA31 as well as E-site codon. 
(e) Interaction of the ε(R)-β-lysyl-hydroxylysine with the CCA-end of P-site tRNAPro 
stabilizes the P-site tRNA as well as the nascent chain, by forcing the prolines to adopt an 
alternative conformation that passes into the ribosomal exit tunnel. (f) Thus, an optimal 
geometry between the nascent chain and the aminoacyl-tRNA in the A-site is achieved 
and peptide bond formation can occur. 
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Table 1 Cryo-EM data collection, refinement and validation statistics 
 
 #1 P-site tRNA only 
 (EMD ID xxxx, 
PDB xxxx) 
#2 A- and P-site 
tRNA + EF-P (EMD 
ID xxxx PDB xxxx) 
#3 P-site tRNA + 
EF-P 
Data collection    
Microscope 
Camera 
Magnification 
Voltage (kV) 
Electron dose (e–/Ǻ2) 
Defocus range (µm) 
Pixel size (Ǻ) 
Initial particles (no.) 
Final  particles (no.) 
FEI Titan Krios 
Falcon II 
129,151 
300 
28 
-0.8 to -2.5 
1.084 
229,613 
75,089 
FEI Titan Krios 
Falcon II 
129,151 
300 
28 
-0.8 to -2.5 
1.084 
229,613 
21,655 
FEI Titan Krios 
Falcon II 
129,151 
300 
28 
-0.8 to -2.5 
1.084 
229,455 
69,761 
    
Model composition 
Protein residues 
RNA bases 
 
Refinement 
 
5,531 
4,547 
 
 
5,951 
4,693 
 
5,944 
4,613 
Resolution range (Å) 
Map CC (around atoms) 
3.3 
0.78 
3.9 
0.72 
3.2 
0.80 
Map CC (whole unit cell) 
FSCaverage 
Map sharpening B factor (Ǻ2) 
0.76 
0.85 
-62,88 
0.75 
0.85 
-66,61 
0.75 
0.85 
-60,10 
R.m.s. deviations    
    Bond lengths (Å) 0.011 0.003 0.007 
    Bond angles (°) 
 
Validation 
MolProbity score 
Clashscore 
Poor rotamers (%) 
 
Ramachandran plot 
Favored (%) 
Allowed (%) 
Disallowed (%) 
0.729 
 
 
1.77 
4.29 
0 
 
 
92.06 
7.76 
0.18 
0.594 
 
 
1.64 
3.44 
0.04 
 
 
91.33 
8.37 
0.31 
0.932 
 
 
1.77 
4.11 
0.41 
 
 
88.83 
10.74 
0.43 
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SUPPLEMENTARY FIGURES 
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Figure S1 Data processing of the cryo-EM structures of polyproline-stalled 
ribosomes ± EF-P. (a) In silico sorting procedure for Dataset 1 derived from the PPP-
stalled ribosome complexes prepared in the absence of EF-P. (b) Fourier-shell-correlation 
(FSC) curve (green) and (c) transverse section of the P-site tRNA only structure colored 
according to local resolution. (d) FSC curve (orange) and (e) transverse section of the A- 
and P-site tRNAs containing structure colored according to local resolution. In (b) and (d), 
the resolution at FSC=0.143 is indicated with a dashed line. (f) In silico sorting procedure 
for Dataset 2 derived from the PPP-SRC prepared in the presence of EF-P. (g) FSC curve 
(orange), as well as self and cross-validated correlations FSCwork (red) and FSCtest 
(purple), respectively. The resolutions at FSC=0.143 and FSC=0.5 (Cref) are indicated 
with dashed lines. (h) Transverse section of the A- and P-site tRNA- and EF-P-containing 
structure colored according to local resolution. (i) FSC curve (green), as well as self and 
cross-validated correlations as in (g) but for the P-site tRNA only structure. (j) as (h) but 
for P-site tRNA only structure. (k) In silico sorting procedure for Dataset 3 derived from 
the PP-SRC prepared in the presence of EF-P. (l) FSC curve (orange), as well as self and 
cross-validated correlations FSCwork (red) and FSCtest (purple), respectively. The 
resolutions at FSC=0.143 and FSC=0.5 (Cref) are indicated with dashed lines. (m) 
Transverse section of the P-site tRNA and EF-P structure colored according to local 
resolution. (n) FSC curve (green) for the P- and E-site tRNA containing structure. (o) as 
(m) but for P- and E-site tRNA containing structure.  
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Figure S2 Flexibility of tRNAPro in A- and P-sites in the absence of EF-P. (a-c) Cryo-
EM densities coloured according to local resolution of the ASL of P-site tRNAPro (green) 
or A-site tRNAPro (orange) in comparison to nucleotides 947-972 (purple) of the 16S 
rRNA at high threshold (7σ). (d-g) Cryo-EM densities of (d,e) P-site tRNAPro (green) and 
(f,g) tRNAPro (orange) coloured according to local resolution at (d-f) high (7σ) or (g) low 
threshold (3.5σ). (h-j) Cryo-EM densities of the CCA-ends of (h) P-site tRNA or (i,j) P- 
and A-site tRNAs including modeled fMet (cyan) and Phe (green) (from PDB ID 
1V4Y)29, coloured according to local resolution. (k) Cryo-EM density colored according 
to local resolution for the N-terminus of ribosomal protein L27 (purple).  
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Figure S3 Comparison of E. coli EF-P, T. thermophilus EF-P and yeast eIF5A on the 
ribosome. (a) Cryo-EM density for EF-P coloured according to local resolution, with EF-
P domains labeled (d1-d3). (b,c) Superimposition of ribosome-bound conformations of 
E. coli EF-P (salmon) with (b) T. thermophilus EF-P (grey) (PDB ID 3HUX)22 and (c) 
yeast eIF5A (light blue) (PDB ID 5GAK)24. Root mean square deviations (RMSD) for 
the individual domains are indicated. (d) Interaction of D69 of E. coli EF-P with 
nucleotide U17a of the D-loop of P-site tRNAPro (green). (e) Interaction of N67 of 
T. thermophilus with nucleotide U17a of the D-loop of P-site tRNAfMet (grey)(PDB ID 
3HUX)22. (f) Absence of interaction of D69 of E. coli EF-P with the D-loop of a tRNATyr 
(cyan, PDB ID 4WQ1) modeled into the P-site of the ribosome. (g-i) Interaction of (g) 
E. coli EF-P, (h) T. thermophilus EF-P (grey)(PDB ID 3HUX)22 and (i) yeast eIF5A 
(light blue) (PDB ID 5GAK)24, with the CCA-end of P-site tRNA as well as A2439 
(blue) of 23S rRNA (A2808 of 28S rRNA in yeast). 
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Figure S4 Interactions of Loop I of domain 3 with S7 and the E-site codon. (a) 
Electron density (grey mesh) for loop I of domain 3 (salmon). (b) Same as (a) but 
coloured according to local resolution. (c) Potential hydrogen bonds between loop I of 
EF-P (salmon), S7 (cyan) and the E-site codon (light blue) are indicated as dashed lines. 
(d) as (c) but only focusing on interactions between S7 and loop I of EF-P. (e) as (c) but 
only focusing on the interactions between the E-site codon and loop I. In (c) and (e), -1, -
2 and -3 nucleotides of the E-site codon are relative to the first position of the P-site 
codon. (f) Weblogo of residues of EF-P loop I (based on 12 different bacterial EF-P 
sequences) and mutation scheme for EF-P variants.  
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Figure S5 Interaction of Loop I of EF-P with the E-site codon. (a,b) Modeling of an 
(a) AAA (magenta) or (b) GGG (blue) codon in the E-site suggests a steric clash with 
residues within loop I of EF-P (salmon). (c,d) Interaction of (c) UUU (olive) or (d) CCG 
(light blue) codon in the E-site with loop I of EF-P and S7 (cyan). Potential hydrogen 
bonds are indicated with dashed yellow lines. Note an additional interaction of loop I of 
EF-P with the -2 position of the (d) proline codon CCG, as compared with (c) 
phenylalanine UUU codon. (e) Lack of interaction of T. thermophilus (grey) loop I of EF-
P with S7 and mRNA (PDB ID 3HUX)22. (f) Comparison of position of R78 of S7 (grey) 
from the T. thermophilus EF-P (grey) 70S structure (PDB ID 3HUX)22 or S7 (cyan) from 
our E. coli EF-P-PP-70S structure. 
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Figure S6 Conformation of polyproline nascent chain on the ribosome. (a-d) 
Comparison of cryo-EM density (mesh) and model for Pro-Pro nascent chain (cyan) 
compared with conformation of diprolyl residues found in (a) S11 (residues 122-124, 
deep olive), (b) L11 (residues 73-75, yellow), (c) the antimicrobial peptide Onc112 
(residues 3-5, olive, PDB ID 4ZER)37, and (d) the CMV-stalling peptidyl-tRNA (orange, 
PDB ID 5A8L)39. (e-f) Comparison of cryo-EM density (mesh) and model for Pro-Pro 
nascent chain (cyan ribbon) with (e) TnaC (yellow, PDB ID 4UY8)40, VemP (dark green, 
PDB ID 5NWY)41 as well as (f) MifM (pink, PDB ID 3J9W)42 and SecM (tan, PDB ID 
3JBV)43. The relative position of nucleotide G2061 (grey) of the 23S rRNA is shown for 
reference.  
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Figure S7 Conformation of polyproline nascent chain on the ribosome. Logarithm of 
the probability of finding a given peptide bond distance along the first (left panel) or the 
second (right) conformational mode of the CCA-end and the C-terminal proline backbone 
atoms obtained from all the simulations. Mode 2 highly correlates (cc=0.89) with the 
peptide bond distance, while mode 1 describes motions that are largely uncorrelated with 
the peptide bond distance (cc=0.23). 
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Supplementary Table 1 Plasmids 
Plasmid Description Source 
pET21b-R1NlpD Used for generation of PPP-SRCs Ref. 25 
pET46LIC_Ec_efp Expression of N-terminal His6-tagged E.coli EF-
P and its variants (see Table 2) 
This study 
pRSFDuet_Ec_yjeK/Ec_yjeA Co-expression with pET46LIC EF-P This study 
 
Supplementary Table 2 Primers 
Primers for Mutation of 
pET46LIC_Ec_efp 
Sequence 
For EF-P-R186A 5’-GGTGAATACGTCTCTGCGGTGAAGTAATGGATC-3’ 
Rev EF-P-R186A 5’-GATCCATTACTTCACCGCAGAGACGTATTCACC-3’ 
For EF-P-Y183A 5’-CCCGCTCTGGTGAAGCGGTCTCTCGCGTGAAG-3’ 
Rev EF-P-Y183A 5’-CTTCACGCGAGAGACCGCTTCACCAGAGCGGG-3’ 
For EF-P-loopIΔ1 5’-CTGAAAGGTGATACCGCAACTGGCGGCAAACCGGC-3’ 
Rev EF-P-loopIΔ1 5’-GCCGGTTTGCCGCCAGTTGCGGTATCACCTTTCAG-3’ 
For EF-P-loopIΔ2 5’-GGCCTGAAAGGTGATACCACTGGCGGCAAACCGGC-3’ 
Rev EF-P-loopIΔ2 5’-GCCGGTTTGCCGCCAGTGGTATCACCTTTCAGGCC-3’ 
For EF-P-loopIΔ3 5’-CCGGGCCTGAAAGGTGATGGCGGCAAACCGGCTACC-3’ 
Rev EF-P-loopIΔ3 5’-GGTAGCCGGTTTGCCGCCATCACCTTTCAGGCCCGG-3’ 
For EF-P-144AAA146 5’-GATCCGGGCCTGAAAGCGGCGGCGGCAGGTACTGGCGGC-3’ 
Rev EF-P-144AAA146 5’-GCCGCCAGTACCTGCCGCCGCCGCTTTCAGGCCCGGATC-3’ 
For EF-P-K34A 5’-CGTAAAACCGGGTGCGGGCCAGGCATTTG-3’ 
Rev EF-P-K34A 5’-CAAATGCCTGGCCCGCACCCGGTTTTACG-3’ 
For EF-P-ΔDomain3 5’-GTTACTCCGCCGAACTAAGTTGAACTGGAAATC-3’ 
Rev EF-P-ΔDomain3 5’-GATTTCCAGTTCAACTTAGTTCGGCGGAGTAAC-3’ 
 
 
